Bioactive molecule-derived covalent organic frameworks as biocompatible scaffolds for targeted AKR1B10 inhibition in alcoholic liver disease
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (47)
Show source-provided references
1. Recent advances in understanding of pathogenesis of alcohol-associated liver disease10.1146/annurev-pathmechdis-031521-030435 ↗
2. Global burden of liver disease: 2023 update10.1016/j.jhep.2023.03.017 ↗
3. Alcoholic hepatitis: the rising epidemic10.1016/j.mcna.2022.12.005 ↗
4. Alcoholic liver disease: a new insight into the pathogenesis of liver disease10.1007/s12272-022-01392-4 ↗
5. Management of alcoholic hepatitis: a clinical perspective10.1111/liv.15701 ↗
6. Current and future treatment for alcoholic-related liver diseases10.1111/jgh.16257 ↗
7. AKR1B10 dictates c-Myc stability to suppress colorectal cancer metastasis via PP2A nitration10.1126/sciadv.adv6937 ↗
8. E2F1-mediated AUF1 upregulation promotes HCC development and enhances drug resistance via stabilization of AKR1B1010.1111/cas.15272 ↗
9. Curcumin attenuates ethanol-induced hepatic steatosis through modulating Nrf2/FXR signaling in hepatocytes10.1002/iub.1409 ↗
10. Silymarin: unveiling its pharmacological spectrum and therapeutic potential in liver diseases-A comprehensive narrative review10.1002/fsn3.4010 ↗
11. Formulation and comparative characterization of nanoparticles of curcumin using natural, synthetic and semi-synthetic polymers for wound healing10.1016/j.lfs.2020.117588 ↗
12. Microwave-assisted, sulfhydryl-modified β-cyclodextrin-silymarin inclusion complex: a diverse approach to improve oral drug bioavailability via enhanced mucoadhesion and permeation
13. Drug-metabolizing cytochrome P450 enzymes have multifarious influences on treatment outcomes10.1007/s40262-021-01001-5 ↗
14. Recent advances in self-targeting natural product-based nanomedicines10.1186/s12951-025-03092-9 ↗
15. Features of anisotropic drug delivery systems10.1002/adma.202307675 ↗
16. Unification of medicines and excipients: the roles of natural excipients for promoting drug delivery10.1080/17425247.2023.2210835 ↗
17. Antiinflammatory and anti-cancer activities of pomegranate and its constituent, ellagic acid: evidence from cellular, animal, and clinical studies10.1002/ptr.6565 ↗
18. Hematoxylin inhibits amyloid β-Protein fibrillation and alleviates amyloid-induced cytotoxicity10.1021/acs.jpcb.6b06878 ↗
19. Inositols depletion and resistance: principal mechanisms and therapeutic strategies10.3390/ijms22136796 ↗
20. Strategies for utilizing covalent organic frameworks as host materials for the integration and delivery of bioactives10.1039/D3MH01492D ↗
21. Landscaping covalent organic framework nanomorphologies10.1021/jacs.2c02301 ↗
22. Covalent organic frameworks: opportunities for rational materials design in cancer therapy10.1002/anie.202314763 ↗
23. In situ enzyme immobilization by covalent organic frameworks10.1002/anie.202213405 ↗
24. Biodegradable redox-responsive AIEgen-Based-Covalent organic framework nanocarriers for long-term treatment of myocardial ischemia/reperfusion injury10.1002/smll.202205062 ↗
25. Sonodynamic therapy of NRP2 monoclonal antibody-guided MOFs@COF targeted disruption of mitochondrial and endoplasmic reticulum homeostasis to induce autophagy-dependent ferroptosis
26. Recent progress in the synthesis and applications of covalent organic framework-based composites10.1039/D3NR05797F ↗
27. Porphyrin-based covalent organic frameworks from design, synthesis to biological applications10.1039/D4BM00214H ↗
28. New potential of boron-based COFs: the biocompatible COF-1 for reactive oxygen generation and antimicrobial applications10.1039/D1TB02808A ↗
29. Microenvironment responsive nanocomposite hydrogel with NIR photothermal therapy, vascularization and anti-inflammation for diabetic infected wound healing
30. Sequential nano-penetrators of capillarized liver sinusoids and extracellular matrix barriers for liver fibrosis therapy10.1021/acsnano.2c03858 ↗
31. Targeted treatment of alcoholic liver disease based on inflammatory signalling pathways10.1016/j.pharmthera.2020.107752 ↗
32. AutoDock Vina 1.2.0: new docking methods, expanded force field, and python bindings10.1021/acs.jcim.1c00203 ↗
33. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading10.1002/jcc.21334 ↗
34. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers10.1016/j.softx.2015.06.001 ↗
35. Manganese tetraphenylporphyrin and carbon nanocoil interface-based electrochemical sensing of tyrosine10.1039/D4RA02048K ↗
36. Selective inhibition of human AKR1B10 by n-humulone, adhumulone and cohumulone isolated from Humulus lupulus extract10.3390/molecules23113041 ↗
37. Magnetic traction and molecular lock-key: nano-intelligent nanobot overcomes glioblastoma ferroptosis resistance to activate ferroptosis-immune10.1016/j.cej.2026.174160 ↗
38. Simultaneous determination of traces amounts of cadmium, zinc, and cobalt based on UV-Vis spectrometry combined with wavelength selection and partial least squares regression10.1016/j.saa.2013.12.086 ↗
39. Protective effect of platinum nano-antioxidant and nitric oxide against hepatic ischemia-reperfusion injury10.1038/s41467-022-29772-w ↗
40. pH-gated nanoparticles selectively regulate lysosomal function of tumour-associated macrophages for cancer immunotherapy10.1038/s41467-023-41592-0 ↗
41. Aging exaggerates acute-on-chronic alcohol-induced liver injury in mice and humans by inhibiting neutrophilic sirtuin 1-C/EBPα-miRNA-223 axis10.1002/hep.32152 ↗
42. Ferroportin-dependent ferroptosis induced by ellagic acid retards liver fibrosis by impairing the SNARE complexes formation10.1016/j.redox.2022.102435 ↗
43. Naturally occurring homoisoflavonoids function as potent protein tyrosine kinase inhibitors by c-Src-based high-throughput screening10.1021/jm701501x ↗
44. The useful predictors of zinc deficiency for the management of chronic liver disease10.1007/s00535-022-01852-0 ↗
45. Dual therapy with zinc acetate and rifaximin prevents from ethanol-induced liver fibrosis by maintaining intestinal barrier integrity10.3748/wjg.v27.i48.8323 ↗
46. Simple way to fabricate emissive boron-containing covalent organic frameworks10.1021/acsami.2c20580 ↗
47. Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release10.1021/acs.chemrev.5b00346 ↗